MK-4482 Ph 2/3 Study in Hospitalized Participants with COVID-19 : A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults with COVID-19 - MK-4482 Ph 2/3 Study in Hospitalized Adults with COVID-19
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
WHO International Clinical Trials Registry Platform - (2021) vom: 06. Dez. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 23-09-2020, Last updated: 2022-11-24 |
|---|
| ICTRP ID: |
EUCTR2020-003367-26-SE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
WHO007591063 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WHO007591063 | ||
| 003 | DE-627 | ||
| 005 | 20230425173334.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210512s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)WHO007591063 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)EUCTR2020-003367-26-SE | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)MK4482-001 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)NCT04575584 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)147734 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)2020-003367-26-FR | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a MK-4482 Ph 2/3 Study in Hospitalized Participants with COVID-19 |b A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults with COVID-19 - MK-4482 Ph 2/3 Study in Hospitalized Adults with COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 23-09-2020, Last updated: 2022-11-24 | ||
| 650 | 4 | |a Medical Condition: COVID-19 MedDRA version: 23.0Level: LLTClassification code 10084382Term: Coronavirus disease 2019System Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02] | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Phase: Phase 2 | |
| 650 | 4 | |a Recruitment Status: Not yet recruiting | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2021) vom: 06. Dez. |
| 773 | 1 | 8 | |g year:2021 |g day:06 |g month:12 |
| 856 | 4 | 0 | |u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003367-26 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 06 |c 12 | ||